Rachel Hemple

White House Licences Key COVID Treatment... The Biden administration has agreed to license several COVID health technologies to the World Health Organization (WHO) to allow global manu...

Market Update: Stocks Jump Higher, but W... Stocks jumped on Friday, as investors looked to shake off losses from earlier this week. The Dow Jones Industrial Average rose over 465 poin...

Pfizer to Acquire Migraine Drugmaker Bio... Pfizer (NYSE: PFE) announced Tuesday it will pay $11.6 billion to acquire Biohaven Pharmaceutical (NYSE: BHVN), marking the pharmaceutical g...

Market Update: Dow Falls for Sixth Strai... Stocks were mostly lower on Thursday as investors tried to calculate the Federal Reserve's next moves amid two more red-hot inflation report...

Market Update: Stocks Fall on Choppy Tra... Stocks fell after a choppy session on Wednesday, as investors digested the latest U.S. inflation data. The Dow Jones Industrial Average drop...

Novavax Posts First Profitable Quarter D... Novavax (NASDAQ: NVAX) on Monday reports its first profitable quarter, driven by its COVID vaccine's global roll-out. However, the shot has...

Market Update: Dow Falls for Fourth Day... Wall Street was met with a choppy trading session on Tuesday as market participants looked for direction following three days of heavy selli...

Bausch + Lomb Leads 4 IPO Week, Busier W... The initial public offering (IPO) market picked up activity last week, with four traditional companies raising over $765 million together in...

Market Update: S&P 500 Falls Below 4,000... Stocks fell sharply on Monday, pulling the S&P 500 down to a fresh 52-week low and extending last week's losses, as investors anticipate to...

Market Update: Stocks Close Out Volatile... Stocks fell Friday amid a volatile day of trading as investors digested a key labor market report with concerns over slowing economic growth...

Moderna COVID Vaccine Triples Sales in Q... Moderna (NASDAQ: MRNA) sold $5.9 billion of its COVID vaccines in the first quarter, topping both revenue and profit expectations as the com...

Market Update: Stocks Give Back Gains, D... Stocks plunged lower on Thursday, giving back gains from Wednesday's afternoon rally, as market participants weighed the Federal Reserve's l...

Pfizer COVID Antiviral Paxlovid Prescrip... Pfizer (NYSE: PFE) on Tuesday said prescriptions for its oral antiviral COVID-19 treatment increased nearly 10-fold in the United States sin...

Market Update: Dow Rallies 900 Points as... Stocks rallied Wednesday afternoon following the Federal Reserve highly anticipated 50-basis-points benchmark rate hike. Fed Chair Jerome Po...

Biotech ETFs May Need to Prepare for Mor... Biotechnology stocks faced their worst April on record, and more pain may be ahead for biotech-focused exchange traded funds (ETF). Popular...

Market Update: Stocks Rise for Second Da... Stocks rose for a second straight day on Tuesday as investors looked ahead to the conclusion of the Federal Reserve's meeting on Wednesday....

Bausch & Lomb Expected to Raise Nearly $... Initial public offering (IPO) market activity picked up last week, with four traditional IPOs raising $266 million. The week ahead is expect...

Market Update: S&P 500, Nasdaq Close Hig... Wall Street staged a late afternoon comeback on Monday, with all three major benchmarks closing up after fluctuating between gains and losse...

Moderna Asks FDA to Authorize COVID Vacc... Modnera (NASDAQ: MRNA) on Thursday asked the U.S. Food and Drug Administration (FDA) to authorize its COVID vaccine for children ages 6 mont...

Pfizer Seeks FDA COVID Booster Shot Auth... Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) asked the U.S. Food and Drug Administration (FDA) earlier this week to authorize a third dose...

Join now and unlock premium features